Success Metrics

Active Trials
1(33%)

Phase Distribution

Ph not_applicable
1
33%

Phase Distribution

0

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution1 total trials
N/ANon-phased studies
1(100.0%)

Highest Phase Reached

Unknown

Trial Status & Enrollment

Completion Rate

0.0%

0 of 0 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

3

all time

Status Distribution
Active(1)
Other(2)

Detailed Status

unknown2
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
3
Active
1
Success Rate
N/A
Most Advanced
N/A

Trials by Phase

N/A1 (100.0%)

Trials by Status

recruiting133%
unknown267%

Recent Activity

1 active trials
Showing 3 of 3
recruiting

CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain Glioma

NCT06234319
unknown

CXCR4 Targeted PET Imaging in the Diagnosis and Identification of Primary Aldosteronism

NCT06183554
unknownnot_applicable

CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis

NCT05839483

Clinical Trials (3)

Showing 3 of 3 trials
NCT06234319

CXCR4 PET/MRI Targeted Imaging for Grading Diagnosis, Molecular Typing, and Prognostic Evaluation of Brain Glioma

Recruiting
NCT06183554

CXCR4 Targeted PET Imaging in the Diagnosis and Identification of Primary Aldosteronism

Unknown
NCT05839483Not Applicable

CXCR4 Targeted PET Imaging in APA Preoperative Localization Diagnosis

Unknown

All 3 trials loaded

Drug Details

Intervention Type
DIAGNOSTIC TEST
Total Trials
3